SOM’s AI-discovered drug shows promise in Huntington’s disease
artificial intelligence, digital, digital health, drug repurposing, Huntington's disease, neurology, SOM Biotech
0 Comment
Huntington’s disease
Ipsen forges $1bn alliance with Exicure on neurodegenerative diseases
Angelman Syndrome, Exicure, Huntington's disease, Ipsen, neurodegenerative disease, partnering, rare disease
0 Comment
UniQure presses go on Huntington’s gene therapy trial
gene therapy, Huntington's disease, rare disease, uniQure
0 Comment
Sanofi hands back neurology gene therapy rights to Voyager
Huntington's disease, neurology, R&D, Sanofi, Voyager Therapeutics
0 Comment
New Huntington’s drug granted priority designation
European Medicines Agency, Huntington's disease, Roche
0 Comment
Roche takes on development of potential Huntington’s breakthrough
antisense drugs, Huntington's disease, Ionis Pharmaceuticals
0 Comment
Huntington’s Disease wearable gets backing from NIH
BioSensics, digital health, Huntington's disease, Teva, wearables
0 Comment
BioSensics’ HDWear provides real-time motor function scores in Huntington’s patients.
FDA approves Teva’s Huntington’s Disease drug
fda, Huntington's disease, neurology, orphan disease, Teva
0 Comment
First treatment approved for Huntington’s Disease in almost a decade.
1 2